What is PathOtrak?
PathOtrak is a specialized biotechnology firm focused on the rapid detection of foodborne pathogens. Its core innovation, the Next Generation Extraction (NGE) System, represents a significant leap forward in diagnostic speed, delivering actionable results in as little as two hours. By drastically reducing incubation times, the company provides a critical service to the fresh produce, poultry, and beef industries, as well as environmental testing sectors. Beyond speed, the platform is designed for operational efficiency, offering a cost-effective alternative that reduces laboratory consumable expenditures by up to 50%. With full USDA and FDA compliance, PathOtrak is uniquely positioned to set new standards for safety and regulatory adherence in the food production landscape.
How much funding has PathOtrak raised?
PathOtrak has raised a total of $2.8M across 3 funding rounds:
Other Financing Round
$300K
Other Financing Round
$300K
Debt
$2.2M
Other Financing Round (2023): $300K with participation from Tedco
Other Financing Round (2024): $300K led by Tedco
Debt (2025): $2.2M, investors not publicly disclosed
Key Investors in PathOtrak
Tedco
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for PathOtrak?
With the recent influx of capital, PathOtrak is expected to scale its manufacturing and distribution capabilities to meet the growing demand for high-throughput pathogen testing. The strategic roadmap likely includes expanding the NGE System's footprint into international markets and further refining its diagnostic sensitivity to address emerging biological threats. As the company matures, the focus will shift toward deepening its integration within large-scale food processing facilities, where the demand for real-time safety data is paramount. This expansion will likely solidify PathOtrak's position as a dominant force in the food safety technology ecosystem, driving long-term value for stakeholders and enhancing public health outcomes through superior diagnostic precision.
See full PathOtrak company page
